Telmisartan protects against high glucose/high lipid‐induced apoptosis and insulin secretion by reducing the oxidative and ER stress
- 25 March 2019
- journal article
- research article
- Published by Wiley in Cell Biochemistry and Function
- Vol. 37 (3) , 161-168
Abstract
Telmisartan, an angiotensin II receptor blocker, has been widely used for hypertension. It has also been reported to improve insulin sensitivity in animal models of obesity and diabetic patients by targeting to the peroxisome proliferator‐activated receptor (PPAR)‐γ. High glucose/high lipid (HG/HL)‐induced apoptosis of pancreatic β‐cells impairs its function of insulin secretion and is generally believed to be the key factor in the development of diabetes. In this study, we investigated whether telmisartan exerted a protective effect against HG/HL‐induced apoptosis and insulin secretion in vitro as well as in vivo; 10‐μM telmisartan treatment significantly reduced HG (25 mM) or/and HL (0.4 mM palmitic acid) induced‐cell apoptosis and greatly improved insulin secretion in INS‐1 pancreatic β‐cells, which is consistent in an obesity rat model induced by HG/HL diets. Furthermore, telmisartan treatment markedly reduced the protein level of GRP78, CHOP, and caspase 12, while increasing anti‐apoptotic Bcl‐2 protein expression. Moreover, telmisartan treatment significantly reduced intracellular ROS levels. Mechanistically, we demonstrated that PPARγ signaling pathway may be involved in the telmisartan protective effects, which were blocked by a PPARγ blocker, GW9662. In conclusion, the protective effect of telmisartan was mediated by an anti‐ER stress‐induced apoptotic and anti‐oxidative pathway. Significance of this study: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder worldwide pathologically characterized by hyperglycemia and insulin resistance. Long‐term high glucose in the blood has been proposed to induce pancreatic β‐cell loss and is generally believed to be the key factor in the development of diabetes. In the present study, we demonstrated that telmisartan, a common drug used for hypertension treatment, has a protective effect against high glucose/high lipid‐induced cell apoptosis and greatly improves the insulin secretion function by inhibiting the oxidative stress and ER stress. Furthermore, this protective effect of telmisartan is mediated by the PPAR‐γ signal pathway, which may provide a potential strategy against T2DM.Keywords
This publication has 34 references indexed in Scilit:
- Nifedipine Protects INS-1 β-Cell from High Glucose-Induced ER Stress and ApoptosisInternational Journal of Molecular Sciences, 2011
- Protective Effect of Heme Oxygenase-1 on High Glucose-Induced Pancreatic β-Cell InjuryDiabetes & Metabolism Journal, 2011
- Quercetin potentiates insulin secretion and protects INS‐1 pancreatic β‐cells against oxidative damage via the ERK1/2 pathwayBritish Journal of Pharmacology, 2010
- Telmisartan attenuates fatty-acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic β-cellsDiabetes & Metabolism, 2009
- Essential role of the unfolded protein response regulator GRP78/BiP in protection from neuronal apoptosisCell Death & Differentiation, 2009
- β-cell apoptosis in type 2 diabetes: quantitative and functional consequencesDiabetes & Metabolism, 2008
- Telmisartan Prevents Obesity and Increases the Expression of Uncoupling Protein 1 in Diet-Induced Obese MiceHypertension, 2006
- Telmisartan But Not Valsartan Increases Caloric Expenditure and Protects Against Weight Gain and Hepatic SteatosisHypertension, 2006
- Endoplasmic reticulum stress: cell life and death decisionsJournal of Clinical Investigation, 2005
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJournal of Clinical Investigation, 1999